Skip to main content
Premium Trial:

Request an Annual Quote

Carl Zeiss, Cellomics Collaborate in NIH Small Molecule Screening Initiative

NEW YORK, July 19 (GenomeWeb News) - Carl Zeiss Microimaging and Cellomics announced on July 18 their involvement in two National Institutes of Health initiatives geared towards bringing small molecule screening to basic science researchers.

 

Zeiss and Cellomics will be contributing products and services to the NIH Molecular Libraries Screening Centers Network and overall Molecular Libraries Initiative. MLSCN research objectives include automation for target-based and cell-based phenotypic assays, software for managing molecular library screening, and informatics tools for data management.

 

Cellomics offers a variety of products for cell-based drug screening, including instrumentation and informatics software. Its confocal-based flagship cellular imaging platform, ArrayScan, utilizes Zeiss' Apotome optical sectioning technology.

 

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.